PERSPECTA

News from every angle

Back to headlines

Hims Expansion Faces Challenges in Risky GLP-1 Business

Hims' expansion efforts may not materialize quickly enough to capitalize on the growing but risky GLP-1 weight-loss drug market.

2 Mar, 14:16 — 2 Mar, 14:16
PostShare